IVD software FDA and CLIA

RegulatoryUS_EU

Involved In Discussions
Hi all,

we are developing a Software (SW) able to interpret raw data coming from next generation sequencing. The SW is able to diagose diseases. In europe, we we would classify the SW as a IVD Medical Device Software (MDSW) regualted under the IVDR

In the FDA will this SW be classified as an IVD or a MD?

Also, in order to obtain the raw data form NGS, blood samples need to be collected and processed. Thus, do we need to certify a lab under CLIA requirements to perform this procedures?

Thanks!
 

ECHO

Involved In Discussions
If you are just taking data from a sequencer and analyzing it, I would think Medical Device.

I think K192073 is similarly analyzing raw sequencing data to make determinations.

Thus, do we need to certify a lab under CLIA requirements to perform this procedures?
Depending on where you lab is located, Yes.
 

RegulatoryUS_EU

Involved In Discussions
Hi ECHO, thank you very much!

The lab is located in the US, thus, I assume a CLIA certification is needed right? in order to speed up the process, it is possible that a third-party lab (familiarized with NGS) procedures recieves the CLIA certification to conduct our procedures? instead of us having to finalize all the lab set up and qualify for CLIA
 
Top Bottom